Connect with us

Technology

The Galien Foundation Honors 2024 Prix Galien Award Recipients

Published

3 hours ago

on

Winners received prestigious award in recognition of latest innovations in advancement in life sciences

NEW YORK, Nov. 8, 2024 /PRNewswire/ — The Galien Foundation, the premier global institution dedicated to honoring innovators in life sciences, celebrated excellence and innovation in life sciences during the Prix Galien USA Forum and 18th annual Prix Galien Awards Gala last night at the American Museum of Natural History in New York City. The USA Committees, composed of 20 committee members, 12 subcommittee members and 20 advisory board members, represented the renowned leaders from the biomedical industry and academia. With three Nobel Laureates, these groups honored this year’s award winners in the following categories: “Best Biotechnology Product,” “Best Pharmaceutical Product,” “Best Product for Rare/Orphan Diseases” “Best Medical Technology,” “Best Digital Health Solution,” “Incubators, Accelerators and Equity” and “Best Startup.”

“On behalf of the Prix Galien USA Awards Committee, we extend our heartfelt gratitude to all nominees and winners for their exceptional efforts in addressing the critical challenges in human health,” said Kenneth Frazier, Prix Galien Committee Chair (categories: Medical Technology, Digital Health, Incubator/Accelerator/Equity, and Startup), former Chairman and Chief Executive Officer, Merck & Co., Inc., Chairman, Health Assurance Initiatives, General Catalyst. “We are inspired by the remarkable achievements and standards set by the Prix Galien Awards nominees and encourage the winners to embrace this moment, honor their accomplishments and continue to exceed their own expectations in the years ahead.”

The 2024 Prix Galien USA Award Winners

Best Biotechnology Product

Daiichi Sankyo & AstraZeneca

ENHERTU®

Best Pharmaceutical Product

Pfizer Inc.

PAXLOVID™

Best Product for Rare/Orphan Diseases

Immunocore

KIMMTRAK®

Best Medical Technology

Butterfly Network

Butterfly iQ3™ Handheld Ultrasound System

Best Digital Health Solution

Viz.ai

Viz HCM™

Incubators, Accelerators and Equity

TMC Innovation

Texas Medical Center Innovation

Best Startup

Pentavere

CervoMed Inc.

 

“The Awards Committee is honored to witness the exceptional dedication and creativity of our nominees as they turn visionary ideas into transformative solutions for patients worldwide. Their unwavering commitment to advancing patient care is truly commendable, and we are honored to celebrate their outstanding contributions to global health,” said Michael Rosenblatt, MD, Chair of the Prix Galien USA Awards Committee, Former Dean of Tufts University School of Medicine, and former Chief Medical Officer of Merck & Co. Inc.

The Roy Vagelos Pro Bono Humanum Award for Global Health Equity was presented to His Serene Highness Prince Albert II of Monaco, in recognition of his unwavering dedication to environmental conservation, scientific innovation, and humanitarian efforts on a global scale. His efforts to address critical issues such as climate change, biodiversity loss, ocean life research, and sustainable development, following the establishment of the Prince Albert II of Monaco Foundation in 2006, continue to have a profoundly positive impact on the well-being of people worldwide.

“We are excited to continue the Prix Galien legacy by honoring another extraordinary group of winners who exemplify the skill, dedication and innovation that is essential to the life sciences industry,” said Bruno Cohen, Chairman of The Galien Foundation. “Our Awards Committee, Prix Galien Alumni, and all members of The Galien Foundation express our sincere appreciation to all winners and nominees, and we eagerly anticipate the significant contributions they will make to the future of global healthcare .”

The Prix Galien Awards were created in 1970 by Roland Mehl in honor of Galien, the father of medical science and modern pharmacology, to recognize outstanding innovation and scientific advancement. With chapters in 14 countries and Africa, with the recent addition of Prix Galien India, Prix Galien is regarded worldwide as the equivalent of the Nobel Prize for the life science industry.

Prix Galien Awards Committee 2024

Biotechnology, Pharmaceutical and Rare/Orphan Diseases:

Michael ROSENBLATT
M.D., Former Dean of Tufts University School of Medicine, and former Chief Medical Officer of Merck & Co. Inc.
Prix Galien Committee Chair

Linda BUCK
Ph.D., Nobel Laureate, Fred Hutchinson Cancer Research Center member; Professor of Physiology and Biophysics, University of Washington

Sue DESMOND-HELLMANN
M.D., M.P.H., Former Chief Executive Officer, Bill & Melinda Gates Foundation

Laurie GLIMCHER
M.D., President and CEO, Dana Farber Cancer Institute, Professor of Medicine, Harvard Medical School

Mary-Claire KING
Ph.D., American Cancer Society Professor of Genome Sciences and Medical Genetics, University of Washington

Robert S. LANGER
M.D., David H. Koch Institute Professor, Massachusetts Institute of Technology

Cato T. LAURENCIN
M.D., Ph.D. University Professor, University of Connecticut

Steven J. LESTER
M.D., Chief Medical Officer, Mayo Clinic-ASU MedTech Accelerator

Stanley B. PRUSINIER
M.D., Nobel Laureate, Professor of Neurology, Director, Institute for Neurodegenerative Diseases, University of California, San Francisco

Philipp A. SHARP
Ph.D., Nobel Laureate, Professor of Biology and member of the Koch Institute, Chair of the advisory board of the MIT Jameel Clinic

Marc TESSIER-LAVIGNE
Ph.D., President, Stanford University

Elie WIESEL
Nobel Peace Prize Laureate, Boston University, Honorary Founding President, In Memoriam

Medical Technology, Digital Health, Incubators, Accelerators and Equity, and Startup:

Kenneth C. FRAZIER
Committee Chair, Former Chairman & CEO Merck

Roch DOLIVEUX
Honorary CEO, UCB

Mikael DOLSTEN
Global R&D President, Pfizer

Alex GORSKY
Former CEO & Executive Chairman, Johnson & Johnson

Penny HEATON
Global Therapeutic Area Head, Vaccines, Janssen

Sheri McCOY
Board of Directors, AstraZeneca, Former CEO, Avon

François MAISONROUGE
Senior Managing Director, Evercore Partners

Joel S. MARCUS
Executive Chairman & Founder, Alexandria

Elias ZERHOUNI
Former Head of Global R&D, Sanofi

Prix Galien Medical Technology Sub-Committee:

Robert S. LANGER
David H. Koch Institute Professor, Massachusetts Institute of Technology

Cato T. LAURENCIN
M.D., Ph.D., University Professor, University of Connecticut

Steven LESTER
M.D., Chief Medical Officer, Mayo Clinic-ASU MedTech Accelerator

Bernard POUSSOT
Director, Roche Holding, Former Chairman & CEO, Wyeth, Chairman Prix Galien, In Memoriam

Prix Galien Incubators, Accelerators, and Equity Category Sub Committee:

Gil BASHE
Managing Partner, Chair Global Health and Purpose, FINN Partners

Ron COHEN
M.D., Founder, President & CEO, Acorda Therapeutics

Jamey EDWARDS
Former CEO, Emergent Medical Associates

Amir KALALI
M.D., Chairman & Chief Curator CNS Summit/Co-Chair Decentralized Trial Research Alliance

Michelle LONGMIRE
M.D., Co-Founder & CEO, Medable Inc.

James PRUTOW
J.D., MBA, Advisory Partner – Life Sciences, Molecular Diagnostics, Global Healthcare, PwC Consulting

Julien de SALABERRY
CEO & Founder, Galen Growth

Prix Galien Startup Advisory Board:

Elaine BRENNAN
Executive Director, Global Strategic Partnerships, Northwell Health

Rodolphe KATRA
Ph.D.,Sr. Research Director & Technical Fellow, Medtronic

Michael LANGER
Founder and Managing Partner at T.Rx Capital

Jonathan MARCHADO
Managing Director, Samsung Next

Detlev MENNERICH
Corporate SVP, Global Head of Business Development &Licensing (BD&L), Boehringer Ingelheim

Leighanne OH
MS, Life Sciences Investor, Novo Holding

Denis PATRIC
Ph.D., Emerging Science & Innovation, Partnering Pfizer

Dennis PURCELL
Founder, Aisling Capital

Prix Galien Digital Health Advisory Board:

Junaid BAJWA
Chief Medical Scientist, Microsoft Research, Microsoft

Ariel KATZ
CEO and Co-foudner, H1

Sachin NANAVATI
Head, Industry, Healthcare, Google

Jay RAJDA
M.D., Clinical Leader, Healthcare, Amazon

MaryAnne RIZK
Ph.D., Managing Partner, Rizk Management Advisors, Adjunct Professor, Stevens Institute of Technology

Steven ROSENBERG
Chief Executive Officer, uMotif

Daniel VIAL
Former Advisor of Sanofi CEO, Healthcare Consultant

About the Galien Foundation 
The Galien Foundation fosters, recognizes and rewards excellence in scientific innovation to improve the state of human health. Our vision is to be the catalyst for the development of the next generation of innovative treatments and technologies that will impact the state of medical practice and save lives.

The Foundation oversees and directs activities in the US for the Prix Galien, an international awards program dedicated to progress through innovative medicines development, with chapters in 14 countries and Africa. The Prix Galien was created in 1970 by Roland Mehl in honor of Galien, the father of medical science and modern pharmacology. Worldwide, the Prix Galien is regarded as the equivalent of the Nobel Prize in biopharmaceutical research.

For more information, visit https://www.galienfoundation.org/.

Follow the Foundation on social media:
https://www.facebook.com/GalienFoundation/ 
https://twitter.com/GalienFdnhttps://www.linkedin.com/company/the-galien-foundation/

Media Contact:
Kara Bradley
Finn Partners
Kara.Bradley@finnpartners.com
646-213-7243

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/the-galien-foundation-honors-2024-prix-galien-award-recipients-302299709.html

SOURCE The Galien Foundation

Related Topics:
Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

Bulletin from the Extraordinary General Meeting in Sivers Semiconductors AB (publ) on 8 November 2024

Published

9 mins ago

on

November 8, 2024

By

NEW YORK, Nov. 8, 2024 /PRNewswire/ — The Extraordinary General Meeting in Sivers Semiconductors AB (publ) (the “Company”) has been held on 8 November 2024 and in particular the following decisions were resolved.

Resolution to approve the Board of Directors’ resolution on a new issue of shares to the CEO

The General Meeting resolved to approve the Board of Directors’ resolution to increase the Company’s share capital by up to SEK 881,168 through the issue of up to 1,762,336 new ordinary shares. The subscription price per ordinary share is SEK 3.972. With deviation from the shareholders’ preferential rights, the new ordinary shares may only be subscribed for by Vickram Vathulya, the CEO of the Company. The subscription price has been determined through agreement between the Board of Directors and Vickram Vathulya and corresponds to the closing price of the ordinary share on Nasdaq Stockholm on 11 October 2024.

For more information, please contact:
Dr. Bami Bastani, Chairman of the Board of Directors 
Tel: +1 908 87 28 370
E-mail: bami.bastani@sivers-semiconductors.com

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/sivers-semiconductors/r/bulletin-from-the-extraordinary-general-meeting-in-sivers-semiconductors-ab–publ–on-8-november-202,c4063583

The following files are available for download:

https://mb.cision.com/Main/11695/4063583/3102744.pdf

Sivers Semiconductors – Bulletin – EGM (8 November) 2024 – #43884673 v2

 

View original content:https://www.prnewswire.com/news-releases/bulletin-from-the-extraordinary-general-meeting-in-sivers-semiconductors-ab-publ-on-8-november-2024-302300106.html

SOURCE Sivers Semiconductors

Continue Reading

Technology

MaidCentral Partners with Maid Brigade to Empower Franchise-Wide Efficiency and Customer Satisfaction for the House Cleaning Industry

Published

9 mins ago

on

November 8, 2024

By

CHARLESTON, S.C., Nov. 8, 2024 /PRNewswire/ — MaidCentral, a premier business management solution for the house cleaning industry, has partnered with Maid Brigade, a leading residential cleaning franchise, to become its official software provider. This strategic partnership aims to elevate operational efficiency, streamline processes, and enhance the customer experience across Maid Brigade’s extensive network of franchise locations throughout the USA and Canada.

“Our partnership with MaidCentral reflects our commitment to equipping Maid Brigade franchises with the most effective tools to optimize their operations,” said Raychel Leong-Sullins, President of Maid Brigade. “With MaidCentral, our franchisees will not only have access to state-of-the-art software but also gain insights that enable them to deliver consistent, five-star service.”

Meeting the Needs of Franchise-Wide Operations

As a fully integrated business management solution, MaidCentral provides tailored functionality that empowers each Maid Brigade franchise to automate scheduling, payroll, KPI tracking, and more. Designed for both independent cleaning companies and large-scale franchises, MaidCentral’s platform consolidates essential functions to improve the day-to-day workflows and overall performance of Maid Brigade’s franchisees.

“MaidCentral’s software aligns with our strategic goals, allowing Maid Brigade to enhance our customer experience while driving operational efficiency across all locations,” added Leong-Sullins. “This partnership is a key part of our growth as we continue to raise the standard for professional residential cleaning services.”

Key Features for Franchisees and Customers Alike

With MaidCentral, Maid Brigade franchisees can manage customer information, scheduling, and employee payroll more seamlessly, helping them focus on what matters most—providing exceptional service. The platform also allows franchisees to track and improve performance metrics in real-time, ultimately enhancing profitability and growth for each location.

Unified Operations: MaidCentral centralizes essential business functions, enabling franchisees to run their operations from a single, intuitive platform.Enhanced Customer Satisfaction: By streamlining operational processes, Maid Brigade franchisees can provide faster, more reliable service to customers nationwide.Performance Tracking: MaidCentral’s platform empowers franchisees to access KPI data, track growth metrics, and make data-driven decisions that benefit the entire franchise network.

“This partnership allows Maid Brigade to utilize technology to its fullest, ensuring a consistent, top-tier experience for all customers, while supporting each franchisee’s growth,” said Tom Stewart, CEO of MaidCentral. “We’re excited to work together to redefine the business management experience for the house cleaning industry.”

About MaidCentral

MaidCentral is a comprehensive business management software solution designed specifically for residential cleaning companies, from single-location businesses to large franchisors. MaidCentral empowers cleaning businesses to optimize scheduling, payroll, KPI tracking, and more, driving greater efficiency and profitability.

About Maid Brigade

Maid Brigade is a national franchise company specializing in professional residential cleaning services. Committed to providing high-quality, eco-friendly cleaning solutions, Maid Brigade has been a trusted name in the house cleaning industry for decades. Through innovative technology and a customer-focused approach, Maid Brigade continually sets new standards for residential cleaning excellence.

For more information, visit: MaidCentral Website | Maid Brigade Website

View original content:https://www.prnewswire.com/news-releases/maidcentral-partners-with-maid-brigade-to-empower-franchise-wide-efficiency-and-customer-satisfaction-for-the-house-cleaning-industry-302299993.html

SOURCE MaidCentral

Continue Reading

Technology

Sparrow BioAcoustics and Killick Capital host launch event for Canada’s First Cardiac AI Application – Stethophone

Published

9 mins ago

on

November 8, 2024

By

Attendees at the event were the first in Canada to see and experience the power of Stethophone firsthand. Stethophone is now available to Canadians on the Apple AppStore..

ST. JOHN’S, NL, Nov. 8, 2024 /PRNewswire-PRWeb/ — Sparrow BioAcoustics, a pioneering Canadian company in the field of bioacoustic medical technology, together with lead investor Killick Capital, is proud to announce the official launch of Stethophone, the first of its kind Cardiac AI application, now available in Canada.

The launch event took place on November 6 at the Emera Innovation Exchange in St. John’s, Newfoundland and Labrador, bringing together distinguished guests from the medical and science communities, provincial and local government officials, members of the press, and key leaders from the medical technology sector.

Stethophone is groundbreaking smartphone application that delivers AI-powered analysis of heart sounds, empowering patients and healthcare professionals alike with cutting-edge tools for early detection of cardiac anomalies. The innovative application was developed entirely by Canadian company Sparrow BioAcoustics and represents a significant leap forward in healthcare technology.

“At Sparrow, we are committed to revolutionizing cardiac care with technology that allows individuals to take charge of their heart health,” said Mark Opauszky, CEO of Sparrow BioAcoustics.

The Government of Canada, through the Atlantic Canada Opportunities Agency (ACOA), is provided federal contribution of $500,000 to Sparrow BioAcoustics to assist with business and product development activities.

“Sparrow BioAcoustics is doing amazing work in the fight against heart disease right here in Newfoundland and Labrador,” said the Honourable Gudie Hutchings, Minister of Rural Economic Development and Minister responsible for ACOA. “With tech like their Stethophone, they are making it easier for folks to access quality heart care in their own homes.”

Attendees at the event were the first in Canada to see and experience the power of Stethophone firsthand. In a live demonstration, guests had the opportunity to try the application themselves and even download it directly from the Apple App Store.

The launch event highlighted the pivotal role that Stethophone will play in Canada’s medical landscape, further cementing the country’s leadership in healthcare innovation.

With its recent approval from Health Canada, Sparrow BioAcoustics is poised to make a lasting impact on both the local and the global stage of medical technology.

For more information about Stethophone and Sparrow BioAcoustics, visit https://stethophone.com/.

About Sparrow BioAcoustics

Sparrow BioAcoustics, with offices in Newfoundland and Nova Scotia, is leading the Software as a Medical Device industry in new directions for cardiac and pulmonary disease detection. Our team of physicians, engineers and data scientists are working to unlock the richest source of diagnostic information about cardiac and pulmonary conditions. Our mission is to help the millions of people at-risk and suffering from cardiac and respiratory disease to live longer, healthier lives enabled by earlier detection and quicker treatment.

Media Contact

Info@sparrowacoustics.com, Sparrow bioacoustics, 1 4162688966, Mark@sparrowacoustics.com, Sparrowbioacoustics.com

View original content to download multimedia:https://www.prweb.com/releases/sparrow-bioacoustics-and-killick-capital-host-launch-event-for-canadas-first-cardiac-ai-application–stethophone-302299022.html

SOURCE Sparrow bioacoustics

Continue Reading

Trending